Skip to main content
Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.29
-0.56 (-3.53%)
At close: Apr 28, 2026, 4:00 PM EDT
15.26
-0.03 (-0.20%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Anika Therapeutics Revenue

In the year 2025, Anika Therapeutics had annual revenue of $112.82M, down -5.91%. Anika Therapeutics had revenue of $30.62M in the quarter ending December 31, 2025, with 0.04% growth.

Revenue (ttm)
$112.82M
Revenue Growth
-5.91%
P/S Ratio
1.83
Revenue / Employee
$480,081
Employees
235
Market Cap
204.90M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025112.82M-7.09M-5.91%
Dec 31, 2024119.91M-885.00K-0.73%
Dec 31, 2023120.79M6.97M6.12%
Dec 31, 2022113.83M-33.97M-22.98%
Dec 31, 2021147.79M17.34M13.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organogenesis Holdings 564.17M
Evolus 297.18M
Aurora Cannabis 272.13M
Akebia Therapeutics 236.20M
Organigram Global 204.21M
Lifecore Biomedical 129.46M
Assertio Holdings 118.71M
SIGA Technologies 94.57M
Revenue Rankings

ANIK News

More News